System Laboratories Secures $20 Million Investment From Patron Fund Vine Courtside Daybreak SV Angel Will Ventures

System Laboratories, Inc. has raised $20 million in funding to support the development of its peptide-native platform designed for physician-guided treatments. The funding will enhance System's capabilities in offering lab-tested peptide treatments across all 50 states, complying with respective state telehealth regulations.

Founded by Adam Steinle, System Laboratories, Inc. collaborates with licensed U.S. clinicians and certified American compounding pharmacies to provide access to peptide treatments that have traditionally been limited to a small group of patients. The investment from key players in the technology and consumer goods sectors reflects the growing interest in the healthcare market and highlights the strategic importance of expanding access to innovative treatments.